Zobrazeno 1 - 2
of 2
pro vyhledávání: '"David Ergaz"'
Publikováno v:
Biomedicines, Vol 9, Iss 2, p 106 (2021)
A 52-year-old woman with a BMI of 31.2 kg/m2 was treated with the glucagon-like peptide 1 (GLP-1) agonist liraglutide as part of her weight-reduction program. Following this, she developed an idiosyncratic drug-related liver injury (IDILI). Advances
Externí odkaz:
https://doaj.org/article/fc94c4278339473586d93d50291705c0
Publikováno v:
Biomedicines
Volume 9
Issue 2
Biomedicines, Vol 9, Iss 106, p 106 (2021)
Volume 9
Issue 2
Biomedicines, Vol 9, Iss 106, p 106 (2021)
A 52-year-old woman with a BMI of 31.2 kg/m2 was treated with the glucagon-like peptide 1 (GLP-1) agonist liraglutide as part of her weight-reduction program. Following this, she developed an idiosyncratic drug-related liver injury (IDILI). Advances
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b536f1efffd7453d87a9b4cb20390ef
https://doi.org/10.3390/biomedicines9020106
https://doi.org/10.3390/biomedicines9020106